American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Papadopoulos
    Papadopoulos
  4. Ponce
    Ponce
  5. Shaffer
    Shaffer
  6. Jakubowski
    Jakubowski
  7. Politikos
    Politikos
  8. Tamari
    Tamari
  9. Dahi
    Dahi
  10. Devlin
    Devlin

Groups

  1. Bone Marrow Transplant (46)
  2. Center for Hematologic Malignancies (46)
  3. Department of Medicine (46)
  4. Hematologic Malignancies, Division of (46)
  5. Survivorship Research (46)
  6. CTCR Scholars (31)
  7. MSK Grad Students (29)
  8. Master of Science in Clinical and Translational Cancer Research (29)
  9. Biostatistics Service (23)
  10. Epidemiology and Biostatistics (23)
Search Within
  1. "Boglarka Gyurkocza"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (8)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (46)
  2. Center for Hematologic Malignancies (46)
  3. Department of Medicine (46)
  4. Hematologic Malignancies, Division of (46)
  5. Survivorship Research (46)
  6. CTCR Scholars (31)

More Groups

People
  1. Boglarka Gyurkocza (46)
  2. Sergio Giralt (37)
  3. Miguel-Angel Perales (29)
  4. Esperanza Papadopoulos (26)
  5. Doris Ponce (24)
  6. Brian Shaffer (23)

More People

Years
  1. 2024 (1)
  2. 2023 (11)
  3. 2022 (6)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Blood (38)
  2. Blood Advances (8)

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation
    Journal Article

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Analysis of 3,843 unrelated donors (URD) for 455 allograft candidates reveals low URD availability with marked racial/ ethnic disparities: Major implications for transplant center & registry operations
    Meeting Abstract

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S. M.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Optimized double-unit cord blood transplantation mitigates transplant-related mortality resulting in high progression-free survival in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Chinapen, S.; Quach, S.; Dahi, P. B.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • (131)I-apamistamab effectively achieved durable responses in patients with R/R AML irrespective of the presence of multiple high-risk factors
    Meeting Abstract

    Seropian, S.; Foran, J. M.; Gyurkocza, B.; Nath, R.; Choe, H.; Litzow, M. R.; Koshy, N.; Stiff, P. J.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • (131)I-apamistamab-led allogeneic hematopoietic cell transplant significantly improves overall survival in patients with TP53 mutated R/R AML
    Meeting Abstract

    Choe, H.; Tomlinson, B. K.; Gyurkocza, B.; Nath, R.; Seropian, S.; Litzow, M. R.; Abboud, C. N.; Stiff, P. J.; Abhyankar, S.; Foran, J. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Topical ruxolitinib for chronic cutaneous GvHD: Promising results of a phase 2 clinical trial
    Meeting Abstract

    Markova, A.; Papadopoulos, E. B.; Dusza, S.; Ostojić, J.; Ai, R.; Maier, T.; Lacouture, M.; Tamari, R.; Gyurkocza, B.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • High progression-free survival with low relapse rates after double-unit cord blood transplantation in patients with high-risk AML
    Meeting Abstract

    Politikos, I.; Fingrut, W. B.; Brown, S.; Chinapen, S.; Quach, S.; Dahi, P. B.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Ponce, D. M.; more...
    Blood (2023)

    Fulltext@MSK | Save